FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086671416> ?p ?o ?g. }

• W2086671416 endingPage "1340" @default.
• W2086671416 startingPage "1334" @default.
• W2086671416 abstract "The present study aimed to identify selective androgen receptor modulators (SARMs) with in vivo pharmacological activity. We examined the in vitro and in vivo pharmacological activity of four chiral, nonsteroidal SARMs synthesized in our laboratories. In the in vitro assays, these compounds demonstrated moderate to high androgen receptor (AR) binding affinity, with K(i) values ranging from 4 to 37 nM, and three of the compounds efficaciously stimulated AR-mediated reporter gene expression. The compounds were then administered subcutaneously to castrated rats to appraise their in vivo pharmacological activity. Androgenic activity was evaluated by the ability of these compounds to maintain the weights of prostate and seminal vesicle, whereas levator ani muscle weight was used as a measure of anabolic activity. The maximal response (E(max)) and dose for half-maximal effect (ED(50)) were determined for each compound and compared with that observed for testosterone propionate (TP). Compounds S-1 and S-4 demonstrated in vivo androgenic and anabolic activity, whereas compounds S-2 and S-3 did not. The activities of S-1 and S-4 were tissue-selective in that both compounds stimulated the anabolic organs more than the androgenic organs. These two compounds were less potent and efficacious than TP in androgenic activity, but their anabolic activity was similar to or greater than that of TP. Neither S-1 nor S-4 caused significant luteinizing hormone or follicle stimulating hormone suppression at doses near the ED(50) value. Thus, compounds S-1 and S-4 were identified as SARMs with potent and tissue-selective in vivo pharmacological activity, and represent the first members of a new class of SARMs with selective anabolic effects." @default.
• W2086671416 created "2016-06-24" @default.
• W2086671416 creator A5002243266 @default.
• W2086671416 creator A5012123010 @default.
• W2086671416 creator A5016676195 @default.
• W2086671416 creator A5036514687 @default.
• W2086671416 creator A5040496579 @default.
• W2086671416 creator A5043693897 @default.
• W2086671416 creator A5050406332 @default.
• W2086671416 creator A5055807052 @default.
• W2086671416 creator A5076766562 @default.
• W2086671416 creator A5083769286 @default.
• W2086671416 date "2002-12-13" @default.
• W2086671416 modified "2023-10-18" @default.
• W2086671416 title "Pharmacodynamics of Selective Androgen Receptor Modulators" @default.
• W2086671416 cites W1975376586 @default.
• W2086671416 cites W1983885442 @default.
• W2086671416 cites W1989381903 @default.
• W2086671416 cites W1989891926 @default.
• W2086671416 cites W1991696538 @default.
• W2086671416 cites W2002383901 @default.
• W2086671416 cites W2008646596 @default.
• W2086671416 cites W2009948262 @default.
• W2086671416 cites W2010054972 @default.
• W2086671416 cites W2013572506 @default.
• W2086671416 cites W2027586930 @default.
• W2086671416 cites W2038310509 @default.
• W2086671416 cites W2043450209 @default.
• W2086671416 cites W2047503568 @default.
• W2086671416 cites W2057233158 @default.
• W2086671416 cites W2064979372 @default.
• W2086671416 cites W2087203144 @default.
• W2086671416 cites W2088284654 @default.
• W2086671416 cites W2097913047 @default.
• W2086671416 cites W2131994141 @default.
• W2086671416 cites W2159615580 @default.
• W2086671416 cites W2177364121 @default.
• W2086671416 cites W2254696577 @default.
• W2086671416 cites W4231324188 @default.
• W2086671416 cites W4234089194 @default.
• W2086671416 cites W4235948306 @default.
• W2086671416 cites W4236069680 @default.
• W2086671416 cites W4241684304 @default.
• W2086671416 doi "https://doi.org/10.1124/jpet.102.040840" @default.
• W2086671416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12604714" @default.
• W2086671416 hasPublicationYear "2002" @default.
• W2086671416 type Work @default.
• W2086671416 sameAs 2086671416 @default.
• W2086671416 citedByCount "138" @default.
• W2086671416 countsByYear W20866714162012 @default.
• W2086671416 countsByYear W20866714162013 @default.
• W2086671416 countsByYear W20866714162014 @default.
• W2086671416 countsByYear W20866714162015 @default.
• W2086671416 countsByYear W20866714162016 @default.
• W2086671416 countsByYear W20866714162018 @default.
• W2086671416 countsByYear W20866714162019 @default.
• W2086671416 countsByYear W20866714162020 @default.
• W2086671416 countsByYear W20866714162021 @default.
• W2086671416 countsByYear W20866714162022 @default.
• W2086671416 countsByYear W20866714162023 @default.
• W2086671416 crossrefType "journal-article" @default.
• W2086671416 hasAuthorship W2086671416A5002243266 @default.
• W2086671416 hasAuthorship W2086671416A5012123010 @default.
• W2086671416 hasAuthorship W2086671416A5016676195 @default.
• W2086671416 hasAuthorship W2086671416A5036514687 @default.
• W2086671416 hasAuthorship W2086671416A5040496579 @default.
• W2086671416 hasAuthorship W2086671416A5043693897 @default.
• W2086671416 hasAuthorship W2086671416A5050406332 @default.
• W2086671416 hasAuthorship W2086671416A5055807052 @default.
• W2086671416 hasAuthorship W2086671416A5076766562 @default.
• W2086671416 hasAuthorship W2086671416A5083769286 @default.
• W2086671416 hasConcept C1008401 @default.
• W2086671416 hasConcept C116073593 @default.
• W2086671416 hasConcept C121608353 @default.
• W2086671416 hasConcept C126322002 @default.
• W2086671416 hasConcept C134018914 @default.
• W2086671416 hasConcept C150903083 @default.
• W2086671416 hasConcept C170493617 @default.
• W2086671416 hasConcept C185592680 @default.
• W2086671416 hasConcept C202751555 @default.
• W2086671416 hasConcept C207001950 @default.
• W2086671416 hasConcept C2777911890 @default.
• W2086671416 hasConcept C2778575703 @default.
• W2086671416 hasConcept C2779279991 @default.
• W2086671416 hasConcept C2780192828 @default.
• W2086671416 hasConcept C2781115071 @default.
• W2086671416 hasConcept C55493867 @default.
• W2086671416 hasConcept C61367390 @default.
• W2086671416 hasConcept C71315377 @default.
• W2086671416 hasConcept C71924100 @default.
• W2086671416 hasConcept C86803240 @default.
• W2086671416 hasConcept C98274493 @default.
• W2086671416 hasConceptScore W2086671416C1008401 @default.
• W2086671416 hasConceptScore W2086671416C116073593 @default.
• W2086671416 hasConceptScore W2086671416C121608353 @default.
• W2086671416 hasConceptScore W2086671416C126322002 @default.
• W2086671416 hasConceptScore W2086671416C134018914 @default.
• W2086671416 hasConceptScore W2086671416C150903083 @default.

• next